Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Left Ventricular Dysfunction

etoposide has been researched along with Left Ventricular Dysfunction in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burggraaf, J; de Roos, A; Lamb, HJ; Osanto, S; Smit, JW; van der Meer, RW; van Elderen, SG; van Schinkel, LD; Willemse, PM1
Altena, R; Brouwer, CA; de Haas, EC; Gietema, JA; Nuver, J; Postma, A; Sleijfer, DT; Smit, AJ; van den Berg, MP1
Altena, R; Boezen, HM; de Boer, RA; de Vries, EG; Gietema, JA; Hummel, YM; Lefrandt, JD; Nuver, J; Smit, AJ; van den Berg, MP; Voors, AA1
Gietema, JA; Hoekstra, HJ; Nuver, J; Sleijfer, DT; Sluiter, WJ; Smit, AJ; van den Berg, MP; van der Meer, J; van Gessel, AI; van Roon, AM1
Ala-Kopsala, M; Hartikainen, J; Husso-Saastamoinen, M; Jantunen, E; Kuittinen, T; Nousiainen, T; Sipola, P; Vuolteenaho, O1
Ala-Kopsala, M; Hartikainen, J; Jantunen, E; Kuittinen, T; Mussalo, H; Nousiainen, T; Vanninen, E; Vuolteenaho, O1
Ahmed, T; Baskind, P; Darzynkiewicz, Z; Feldman, EJ; Goff, H; Pozzuoli, M; Santos, S; Seiter, K; Traganos, F1

Trials

1 trial(s) available for etoposide and Left Ventricular Dysfunction

ArticleYear
Phase II evaluation of a high-dose mitoxantrone based induction regimen in untreated adults with acute myeloid leukemia.
    Leukemia & lymphoma, 2000, Volume: 38, Issue:3-4

    Topics: Actuarial Analysis; Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Conjunctivitis; Cytarabine; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Humans; Hyperbilirubinemia; Leukemia, Myeloid; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Remission Induction; Risk; Stomatitis; Stroke Volume; Survival Analysis; Survival Rate; Treatment Outcome; Tretinoin; Ventricular Dysfunction, Left

2000

Other Studies

6 other study(ies) available for etoposide and Left Ventricular Dysfunction

ArticleYear
Chemotherapy for testicular cancer induces acute alterations in diastolic heart function.
    British journal of cancer, 2013, Aug-20, Volume: 109, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiac-Gated Imaging Techniques; Cisplatin; Diastole; Etoposide; Heart; Humans; Insulin Resistance; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myocardium; Seminoma; Testicular Neoplasms; Triglycerides; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Function, Right; Young Adult

2013
Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer.
    British journal of cancer, 2009, Jun-16, Volume: 100, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cohort Studies; Echocardiography; Etoposide; Heart; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Orchiectomy; Peptide Fragments; Prognosis; Prospective Studies; Risk Factors; Testicular Neoplasms; Ventricular Dysfunction, Left; Young Adult

2009
Longitudinal changes in cardiac function after cisplatin-based chemotherapy for testicular cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease Progression; Echocardiography; Etoposide; Galectin 3; Heart Diseases; Humans; Longitudinal Studies; Male; Middle Aged; Natriuretic Peptide, Brain; Testicular Neoplasms; Ventricular Dysfunction, Left; Young Adult

2011
Left ventricular and cardiac autonomic function in survivors of testicular cancer.
    European journal of clinical investigation, 2005, Volume: 35, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Autonomic Nervous System Diseases; Baroreflex; Bleomycin; Blood Pressure; Cardiomyopathies; Cisplatin; Echocardiography, Doppler; Etoposide; Humans; Male; Middle Aged; Orchiectomy; Testicular Neoplasms; Ventricular Dysfunction, Left

2005
Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
    Bone marrow transplantation, 2005, Volume: 36, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular System; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Heart; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Natriuretic Peptides; Peptides; Prospective Studies; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Ventricular Dysfunction, Left; Ventricular Function, Left

2005
Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
    European journal of haematology, 2006, Volume: 77, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Atrial Natriuretic Factor; Biomarkers; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Gated Blood-Pool Imaging; Heart; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Postoperative Period; Prospective Studies; Protein Precursors; Sensitivity and Specificity; Stroke Volume; Systole; Transplantation, Autologous; Ventricular Dysfunction, Left

2006